Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

R-Nex 120 - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/R-Nex 120

Approved

STANDARD

R-Nex 120

Rhydburg Pharmaceuticals Ltd.🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: 55edc917849c5b29
Company: Rhydburg Pharmaceuticals Ltd.
Type: Standard

Approval Details

Approval Id: 55edc917849c5b29
Drug Approval Philippines Name: R-Nex 120
Product Name: R-Nex 120
Registration Number: DRP-13653
Brand Name: R-Nex 120
Generic Name: Paracetamol
Dosage Form: Oral Suspension
Dosage Strength: 120 mg/5 mL
Manufacturer: Rhydburg Pharmaceuticals Ltd.
Trader: India
Distributor: Genedrift Philippines OPC
Issuance Date: 24 March 2023
Expiry Date: 24 March 2028
Classification: Over-the-Counter (OTC)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

55edc917849c5b29

Type

Standard

Back to Philippines FDA Approvals